Gluud LL - Search Results

1

The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease.

Krag A, Wiest R, Albillos A, Gluud LL. Krag A, et al. Among authors: gluud ll. Gut. 2012 Jul;61(7):967-9. doi: 10.1136/gutjnl-2011-301348. Epub 2012 Jan 10. Gut. 2012. PMID: 22234982 No abstract available.

2

Characteristics of randomised trials on diseases in the digestive system registered in ClinicalTrials.gov: a retrospective analysis.

Wildt S, Krag A, Gluud L. Wildt S, et al. BMJ Open. 2011 Jan 1;1(2):e000309. doi: 10.1136/bmjopen-2011-000309. BMJ Open. 2011. PMID: 22080540 Free PMC article.

3

Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy.

Holte K, Krag A, Gluud LL. Holte K, et al. Among authors: gluud ll. Hepatol Res. 2012 Oct;42(10):1008-15. doi: 10.1111/j.1872-034X.2012.01015.x. Epub 2012 Apr 30. Hepatol Res. 2012. PMID: 22548675

4

Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.

Gluud LL, Krag A. Gluud LL, et al. Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD004544. doi: 10.1002/14651858.CD004544.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895942 Free PMC article. Review.

5

Terlipressin for hepatorenal syndrome.

Gluud LL, Christensen K, Christensen E, Krag A. Gluud LL, et al. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD005162. doi: 10.1002/14651858.CD005162.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Jun 14;6:CD005162. doi: 10.1002/14651858.CD005162.pub4 PMID: 22972083 Updated. Review.

6

Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials.

Kimer N, Dahl EK, Gluud LL, Krag A. Kimer N, et al. Among authors: gluud ll. BMJ Open. 2012 Oct 22;2(5):e001313. doi: 10.1136/bmjopen-2012-001313. Print 2012. BMJ Open. 2012. PMID: 23089208 Free PMC article.

7

[Hepatorenal syndrome: diagnosis, treatment and prevention].

Egerod Israelsen M, Gluud LL, Bendtsen F, Møller S, Krag AA. Egerod Israelsen M, et al. Among authors: gluud ll. Ugeskr Laeger. 2013 May 27;175(22):1562-6. Ugeskr Laeger. 2013. PMID: 23721840 Review. Danish.

8

Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?

Thiele M, Wiest R, Gluud LL, Albillos A, Krag A. Thiele M, et al. Among authors: gluud ll. Med Hypotheses. 2013 Nov;81(5):871-4. doi: 10.1016/j.mehy.2013.08.026. Epub 2013 Sep 4. Med Hypotheses. 2013. PMID: 24060485

9

Cross-talk between the liver, heart and kidney - another piece in the puzzle.

Krag A, Gluud LL. Krag A, et al. Among authors: gluud ll. J Gastrointestin Liver Dis. 2014 Jun;23(2):119-21. doi: 10.15403/jgld.2014.1121.ak1. J Gastrointestin Liver Dis. 2014. PMID: 24949601 Free article. No abstract available.

10

Acute kidney injury and hepatorenal syndrome in cirrhosis.

Egerod Israelsen M, Gluud LL, Krag A. Egerod Israelsen M, et al. Among authors: gluud ll. J Gastroenterol Hepatol. 2015 Feb;30(2):236-43. doi: 10.1111/jgh.12709. J Gastroenterol Hepatol. 2015. PMID: 25160511 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters